The KDM1A and KDM7A lysine demethylases cooperate to regulate androgen receptor function in prostate cancer cells [KDM1A & KDM7A inhibitors]
RNA-seq (gene expression) · human · 12 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 12 samples: 6 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancerMolecular oncology · 2026
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE194279_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA800050 and SRA study SRP356467. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 12 samples.
How we read this: 6 replicated groups read from 12 sample titles; they account for 12 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM5832200 LNCaP R1881 rep 1 LNCaP R1881
- GSM5832201 LNCaP R1881 rep 2 LNCaP R1881
- GSM5832202 LNCaP R1881 + Namoline + TCE-5002 rep 1 LNCaP R1881 + Namoline …
- GSM5832203 LNCaP R1881 + Namoline + TCE-5002 rep 2 LNCaP R1881 + Namoline …
- GSM5832204 LNCaP:C42 R1881 rep 1 C42 R1881
- GSM5832205 LNCaP:C42 R1881 rep 2 C42 R1881
- GSM5832206 LNCaP:C42 R1881 TCE-5002 rep 1 C42 R1881 TCE-5002
- GSM5832207 LNCaP:C42 R1881 TCE-5002 rep 2 C42 R1881 TCE-5002
- GSM5832208 LNCaP:C42 R1881 + Namoline rep 1 C42 R1881 + Namoline
- GSM5832209 LNCaP:C42 R1881 + Namoline rep 2 C42 R1881 + Namoline
- GSM5832210 LNCaP:C42 R1881 + Namoline + TCE-5002 rep 1 C42 R1881 + Namoline + …
- GSM5832211 LNCaP:C42 R1881 + Namoline + TCE-5002 rep 2 C42 R1881 + Namoline + …
- GSE194281 The KDM1A and KDM7A lysine demethylases cooperate to regulate androgen receptor function in prostate cancer cells 30 samples shares kdm1a, kdm7a, demethylases, cooperate, regulate, androgen, receptor
- GSE222196 Treatment of prostate cancer cell lines with Androgen Receptor and Receptor Tyrosine Kinase inhibitors 246 samples shares inhibitors, androgen, receptor
- GSE281302 ESR1 Y537S and D538G mutations drive resistance to CDK4/6 inhibitors in estrogen receptor-positive breast cancer 36 samples shares inhibitors, receptor
- GSE285827 PARP inhibitors differentially regulate immune responses in distinct genetic backgrounds of high-grade serous tubo-ovarian carcinoma 18 samples shares inhibitors, regulate
- GSE228074 The epigenetic regulatory role of KDM1A in HCC cells [HepG2_shKDM1A_CUTTag_seq] 11 samples shares kdm1a
- GSE261195 CDKN1B (p27kip1) enhances drug tolerant persister CTCs by restricting polyploidy following mitotic inhibitors. 320 samples shares inhibitors
- GSE297400 Transcriptome Profiling of Human Dermal Fibroblasts Treated with 4 Phosphodiesterase Inhibitors Across Multiple Dose Gradients 199 samples shares inhibitors
- GSE252002 In vitro drug screening of RAF/MEK/ERK Inhibitors in two PDA Cell Lines 152 samples shares inhibitors
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.